The anti-inflammatory effect of A₃adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis

This publication has 70 references indexed in Scilit:

• Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor
  Nature Clinical Practice Rheumatology, 2006
• Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis
  New England Journal of Medicine, 2006
• New insights into the regulation of inflammation by adenosine
  Journal of Clinical Investigation, 2006
• The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
  Journal of Clinical Investigation, 2006
• Multiple Signaling States of G-Protein-Coupled Receptors
  Pharmacological Reviews, 2005
• Leflunomide in rheumatoid arthritis: recommendations through a process of consensus
  Rheumatology, 2005
• The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry
  Arthritis & Rheumatism, 2001
• Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions
  Trends in Pharmacological Sciences, 1994
• Rheumatoid Arthritis
  New England Journal of Medicine, 1990
• The cellular basis of adjuvant arthritis
  Cellular Immunology, 1983